CDMRP Ovarian Cancer Investigator-Initiated Research Award


Funding Opportunity ID: 331383
Opportunity Number: W81XWH-21-OCRP-IIRA
Opportunity Title: CDMRP Ovarian Cancer Investigator-Initiated Research Award
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Cooperative Agreement
Category of Funding Activity: Science and Technology and other Research and Development
Category Explanation:
CFDA Number(s): 12.420
Eligible Applicants: Unrestricted (i.e., open to any type of entity above), subject to any clarification in text field entitled “Additional Information on Eligibility”
Additional Information on Eligibility:
Agency Code: DOD-AMRAA
Agency Name: Department of Defense
Dept. of the Army — USAMRAA
Posted Date: Feb 08, 2021
Close Date: Jul 08, 2021
Last Updated Date: Feb 08, 2021
Award Ceiling: $0
Award Floor: $0
Estimated Total Program Funding: $11,840,000
Expected Number of Awards: 11
Description: The OCRP Investigator-Initiated Research Award is intended to support high-impact research that addresses a critical need and has the potential to make an important contribution to ovarian cancer or patient/survivor care. Research projects may focus on any phase of research, from basic laboratory research through translational research, excluding clinical trials. The application must demonstrate logical reasoning and a sound scientific rationale established through a critical review and analysis of the literature for the application to be competitive. Applications must include preliminary data that are relevant to ovarian cancer and support the proposed research project. These data may be unpublished or from the published literature. If cell lines or animals are to be used, a clear justification should be provided for the choice of proposed cell line(s) or animal model(s).Clinical trials are not supported with this award mechanism.New for FY21 is the Partnering PI Option: As a method to facilitate progress in addressing critical problems or questions through collaborative efforts, the FY21 OCRP is offering a Partnering PI Option for this award mechanism. The Partnering PI Option is structured so that two investigators, each of whom will be designated as a PI, work synergistically on a single project. If recommended for funding, each PI will be named to an individual award within the recipient organization.
Version: 1

Visit the Official Webpage For More Details on CDMRP Ovarian Cancer Investigator-Initiated Research Award


Please enter your comment!
Please enter your name here